$153.89 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Medpace

Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Stock Analysis

last close $153.89
1-mo return 15.4%
3-mo return -4.1%
avg daily vol. 387.2T
52-week high 231
52-week low 126.95
market cap. $4.9B
forward pe 26.8
annual div. -
roe 27.3%
ltg forecast -
dividend yield -
annual rev. $1.2B
inst own. 88.5%

Subscribe now for daily local and international financial news